ArticleContemporary oncology (Poznan, Poland)2015

Cell-based Hyper-interleukin 6 or Hyper-interleukin 11 secreting vaccines combined with low dose cyclophosphamide in an orthotopic murine prostate cancer model.

Jacek Mackiewicz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.